Publication | Open Access
Phase 1b Study of Sintilimab Plus Anlotinib as First-line Therapy in Patients With Advanced NSCLC
216
Citations
32
References
2021
Year
Phase 1BAdvanced NsclcSintilimab Plus AnlotinibOncologyClinical TherapeuticMedicineClinical TrialsPharmacotherapyPharmacology
| Year | Citations | |
|---|---|---|
Page 1
Page 1